Tracked deals
4
4 tracked deals across 2022-2025.
Private Equity Firm
Healthcare
Quadria Capital
Singapore, Singapore, Singapore
Quadria Capital is Asia’s healthcare private equity firm, managing over US$4.3B in assets and investing across healthcare delivery, life sciences, medical technology, and related healthcare services in South and Southeast Asia.
- Focus Areas
- Healthcare delivery, Life sciences, Medical technology
- Website
- quadriacapital.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
2 buyout · 2 growth capital
Quadria Capital Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
July 24, 2025
- Buyer
- Straits Orthopaedics (Mfg) Sdn Bhd, Quadria Capital
- Target
- Medin Technologies, Inc.
- Industry
- Medical Devices
- Location
- New Jersey, United States
- Type
- Buyout
Straits Orthopaedics (Mfg) Sdn Bhd has acquired Medin Technologies, Inc., a U.S.-based manufacturer of sterilization cases and trays that operates facilities in Totowa, New Jersey and Manchester, New Hampshire. The deal expands Straits’ product offerings and global manufacturing footprint for orthopaedic OEM customers; Straits is backed by Quadria Capital.
-
- Buyer
- CopilotIQ, Biofourmis, General Atlantic, Openspace Ventures, Bessemer Venture Partners
- Target
- CopilotIQ, Biofourmis
- Industry
- Healthcare Services
- Location
- United States
- Type
- Buyout
CopilotIQ and Biofourmis announced a strategic merger to create a combined, end-to-end AI-driven platform for in‑home care spanning pre-surgery, acute, post-acute, and chronic care. Leading investors from both companies — including General Atlantic, Openspace Ventures, and Bessemer Venture Partners — are reinvesting in the combined business to support expansion and product integration.
-
- Buyer
- Quadria Capital
- Target
- NephroPlus
- Seller
- Investcorp, Bessemer Venture Partners, IFC, IIFL Private Equity
- Industry
- Healthcare Services
- Location
- Telangana, India
- Type
- Growth capital
Quadria Capital led a $102 million funding round in NephroPlus that combines primary capital and a secondary purchase of stakes from existing investors, including Investcorp, Bessemer Venture Partners, IFC and IIFL Private Equity. Investcorp retains a significant minority stake; the new capital will be used to fund organic growth in India and further international expansion of NephroPlus, Asia's largest dialysis service network headquartered in Hyderabad.
-
- Buyer
- General Atlantic, CVS Health, SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital, EDBI
- Target
- Biofourmis
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Type
- Growth capital
Biofourmis, a virtual care and digital medicine company headquartered in Needham/Boston, raised $300 million in a Series D growth round led by General Atlantic, with participation from CVS Health and existing investors including SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. The capital will be used to scale Biofourmis’ Care@Home virtual care platform, expand virtual specialty care and digital therapeutics programs, and accelerate clinical trials and partnerships in value-based care.
Related Acquisition Pages
Selling a company? Get in front of buyers like Quadria Capital
Turn tracked acquisition activity into an outreach-ready buyer list.